Allele-specific loss and transcription of the miR-15a/16-1 cluster in chronic lymphocytic leukemia

Leukemia

Volumn 29, Issue 1, 2015, Pages 86-95

  Veronese, A ^a   Pepe, F ^a   Chiacchia, J ^a   Pagotto, S ^a   Lanuti, P ^a   Veschi, S ^a   Di Marco, M ^a   D'Argenio, A ^a   Innocenti, I ^b   Vannata, B ^b   Autore, F ^b   Marchisio, M ^a   Wernicke, D ^c   Verginelli, F ^a   Leone, G ^b   Rassenti, L Z ^d,e   Kipps, T J ^d,e   Mariani Costantini, R ^a   Laurenti, L ^b   Croce, C M ^c,e   Visone, R ^a   more..

^a UNIVERSITY OF CHIETI   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c OHIO STATE UNIVERSITY   (United States)

^d UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^e Chronic Lymphocytic Leukemia Research Consortium   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN E; DNA; DNA DIRECTED RNA POLYMERASE III; MICRORNA; MICRORNA 15A; MICRORNA 16 1; PROTEIN BCL 2; PROTEIN KINASE ZAP 70; PROTEIN P53; RNA POLYMERASE II; UNCLASSIFIED DRUG; MIRN15 MICRORNA, HUMAN; MIRN16 MICRORNA, HUMAN; TUMOR MARKER;

ALLELE; ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CHROMOSOME DELETION; CHRONIC LYMPHATIC LEUKEMIA; COMPARATIVE STUDY; CONTROLLED STUDY; COPY NUMBER VARIATION; FLUORESCENCE ACTIVATED CELL SORTING; GENE LOCUS; GENETIC TRAIT; HEK293 CELL LINE; HETEROZYGOSITY; HUMAN; HUMAN CELL; MOLECULAR MODEL; MONOZYGOTIC TWINS; PERIPHERAL BLOOD MONONUCLEAR CELL; PROMOTER REGION; REGULATORY SEQUENCE; RNA TRANSCRIPTION; SINGLE NUCLEOTIDE POLYMORPHISM; CHROMATIN IMMUNOPRECIPITATION; GENETIC TRANSCRIPTION; GENETICS; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; REAL TIME POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

ALLELES; BASE SEQUENCE; BIOMARKERS, TUMOR; CELL LINE, TUMOR; CHROMATIN IMMUNOPRECIPITATION; DNA; DNA COPY NUMBER VARIATIONS; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MICRORNAS; MOLECULAR SEQUENCE DATA; POLYMORPHISM, SINGLE NUCLEOTIDE; REAL-TIME POLYMERASE CHAIN REACTION; TRANSCRIPTION, GENETIC;

EID: 84920689479     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2014.139     Document Type: Article

References (60)

1. Chiorazzi N, Rai KR, Ferrarini M. Chronic lymphocytic leukemia. N Engl J Med 2005; 352: 804-815.
2. Bosch F, Montserrat E. Refining prognostic factors in chronic lymphocytic leukemia. Rev Clin Exp Hematol 2002; 6: 335-349, discussion 449-350.
3. Edelmann J, Holzmann K, Miller F, Winkler D, Buhler A, Zenz T et al. High-resolution genomic profiling of chronic lymphocytic leukemia reveals new recurrent genomic alterations. Blood 2012; 120: 4783-4794.
4. Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E et al. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 2002; 99: 15524-15529.
5. Calin GA, Ferracin M, Cimmino A, Di Leva G, Shimizu M, Wojcik SE et al. A microRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 2005; 353: 1793-1801.
6. Landau DA, Carter SL, Stojanov P, McKenna A, Stevenson K, Lawrence MS et al. Evolution and impact of subclonal mutations in chronic lymphocytic leukemia. Cell 2013; 152: 714-726.
7. Rawstron AC. Monoclonal B-cell lymphocytosis. Hematology Am Soc Hematol Educ Program 2009; 430-439.
8. Rossi D, Sozzi E, Puma A, De Paoli L, Rasi S, Spina V et al. The prognosis of clinical monoclonal B cell lymphocytosis differs from prognosis of Rai 0 chronic lym-phocytic leukaemia and is recapitulated by biological risk factors. Br J Haematol 2009; 146: 64-75.
9. Rawstron AC, Bennett FL, O'Connor SJ, Kwok M, Fenton JA, Plummer M et al. Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia. N Engl J Med 2008; 359: 575-583.
10. Krober A, Seiler T, Benner A, Bullinger L, Bruckle E, Lichter P et al. V(H) mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia. Blood 2002; 100: 1410-1416.
11. Dohner H, Stilgenbauer S, Benner A, Leupolt E, Krober A, Bullinger L et al. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 2000; 343: 1910-1916.
12. Ouillette P, Collins R, Shakhan S, Li J, Li C, Shedden K et al. The prognostic significance of various 13q14 deletions in chronic lymphocytic leukemia. Clin Cancer Res 2011; 17: 6778-6790.
13. Ouillette P, Erba H, Kujawski L, Kaminski M, Shedden K, Malek SN. Integrated genomic profiling of chronic lymphocytic leukemia identifies subtypes of deletion 13q14. Cancer Res 2008; 68: 1012-1021.
14. Klein U, Lia M, Crespo M, Siegel R, Shen Q, Mo T et al. The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia. Cancer Cell 2010; 17: 28-40.
15. Fabbri M, Bottoni A, Shimizu M, Spizzo R, Nicoloso MS, Rossi S et al. Association of a microRNA/TP53 feedback circuitry with pathogenesis and outcome of B-cell chronic lymphocytic leukemia. JAMA 2011; 305: 59-67.
16. Aqeilan RI, Calin GA, Croce CM. miR-15a and miR-16-1 in cancer: discovery, function and future perspectives. Cell Death Differ 2010; 17: 215-220.
17. Calin GA, Cimmino A, Fabbri M, Ferracin M, Wojcik SE, Shimizu M et al. MiR-15a and miR-16-1 cluster functions in human leukemia. Proc Natl Acad Sci USA 2008; 105: 5166-5171.
18. Mertens D, Philippen A, Ruppel M, Allegra D, Bhattacharya N, Tschuch C et al. Chronic lymphocytic leukemia and 13q14: miRs and more. Leuk Lymphoma 2009; 50: 502-505.
19. Mertens D, Wolf S, Tschuch C, Mund C, Kienle D, Ohl S et al. Allelic silencing at the tumor-suppressor locus 13q14.3 suggests an epigenetic tumor-suppressor mechanism. Proc Natl Acad Sci USA 2006; 103: 7741-7746.
20. Suzuki HI, Yamagata K, Sugimoto K, Iwamoto T, Kato S, Miyazono K. Modulation of microRNA processing by p53. Nature 2009; 460: 529-533.
21. Calin GA, Trapasso F, Shimizu M, Dumitru CD, Yendamuri S, Godwin AK et al. Familial cancer associated with a polymorphism in ARLTS1. N Engl J Med 2005; 352: 1667-1676.
22. Rassenti LZ, Huynh L, Toy TL, Chen L, Keating MJ, Gribben JG et al. ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia. N Engl J Med 2004; 351: 893-901.
23. Wendel-Hansen V, Sallstrom J, De Campos-Lima PO, Kjellstrom G, Sandlund A, Siegbahn A et al. Epstein-Barr virus (EBV) can immortalize B-cll cells activated by cytokines. Leukemia 1994; 8: 476-484.
24. Stacchini A, Aragno M, Vallario A, Alfarano A, Circosta P, Gottardi D et al. MEC1 and MEC2: two new cell lines derived from B-chronic lymphocytic leukaemia in prolymphocytoid transformation. Leuk Res 1999; 23: 127-136.
25. Doyle MG, Catovsky D, Crawford DH. Infection of leukaemic B lymphocytes by Epstein Barr virus. Leukemia 1993; 7: 1858-1864.
26. Lachmann R, Lanuti P, Miscia S. OMIP-011: characterization of circulating endo-thelial cells (CECs) in peripheral blood. Cytometry A 2012; 81: 549-551.
27. Lanuti P, Ciccocioppo F, Bonanni L, Marchisio M, Lachmann R, Tabet N et al. Amyloid-specific T-cells differentiate Alzheimer's disease from Lewy body dementia. Neurobiol Aging 2012; 33: 2599-2611.
28. Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee DH, Nguyen JT et al. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 2005; 33: e179.
29. Varkonyi-Gasic E, Wu R, Wood M, Walton EF, Hellens RP. Protocol: a highly sensitive RT-PCR method for detection and quantification of microRNAs. Plant Methods 2007; 3: 12.
30. Tang F, Hajkova P, Barton SC, Lao K, Surani MA. MicroRNA expression profiling of single whole embryonic stem cells. Nucleic Acids Res 2006; 34: e9.
31. Visone R, Rassenti LZ, Veronese A, Taccioli C, Costinean S, Aguda BD et al. Karyotype-specific microRNA signature in chronic lymphocytic leukemia. Blood 2009; 114: 3872-3879.
32. Bichi R, Shinton SA, Martin ES, Koval A, Calin GA, Cesari R et al. Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression. Proc Natl Acad Sci USA 2002; 99: 6955-6960.
33. Zeng Y, Cullen BR. Efficient processing of primary microRNA hairpins by Drosha requires flanking nonstructured RNA sequences. J Biol Chem 2005; 280: 27595-27603.
34. Wu M, Jolicoeur N, Li Z, Zhang L, Fortin Y, L'Abbe D et al. Genetic variations of microRNAs in human cancer and their effects on the expression of miRNAs. Carcinogenesis 2008; 29: 1710-1716.
35. Iwai N, Naraba H. Polymorphisms in human pre-miRNAs. Biochem Biophys Res Commun 2005; 331: 1439-1444.
36. Han SJ, Marshall V, Barsov E, Quinones O, Ray A, Labo N et al. Kaposi's sarcoma-associated herpesvirus microRNA single-nucleotide polymorphisms identified in clinical samples can affect microRNA processing, level of expression, and silencing activity. J Virol 2013; 87: 12237-12248.
37. Ryan BM, Robles AI, Harris CC. Genetic variation in microRNA networks: the implications for cancer research. Nat Rev Cancer 2010; 10: 389-402.
38. Fukuda T, Yamagata K, Fujiyama S, Matsumoto T, Koshida I, Yoshimura K et al. DEAD-box RNA helicase subunits of the Drosha complex are required for processing of rRNA and a subset of microRNAs. Nat Cell Biol 2007; 9: 604-611.
39. Schramm L, Hernandez N. Recruitment of RNA polymerase III to its target promoters. Genes Dev 2002; 16: 2593-2620.
40. Raha D, Wang Z, Moqtaderi Z, Wu L, Zhong G, Gerstein M et al. Close association of RNA polymerase II and many transcription factors with Pol III genes. Proc Natl Acad Sci USA 2010; 107: 3639-3644.
41. Monteys AM, Spengler RM, Wan J, Tecedor L, Lennox KA, Xing Y et al. Structure and activity of putative intronic miRNA promoters. RNA 2010; 16: 495-505.
42. Wang Z, Roeder RG. Three human RNA polymerase III-specific subunits form a subcomplex with a selective function in specific transcription initiation. Genes Dev 1997; 11: 1315-1326.
43. Sepehri S, Hernandez N. The largest subunit of human RNA polymerase III is closely related to the largest subunit of yeast and trypanosome RNA polymerase III. Genome Res 1997; 7: 1006-1019.
44. Lerner M, Harada M, Loven J, Castro J, Davis Z, Oscier D et al. DLEU2, frequently deleted in malignancy, functions as a critical host gene of the cell cycle inhibitory microRNAs miR-15a and miR-16-1. Exp Cell Res 2009; 315: 2941-2952.
45. Lee Y, Kim M, Han J, Yeom KH, Lee S, Baek SH et al. MicroRNA genes are transcribed by RNA polymerase II. EMBO J 2004; 23: 4051-4060.
46. James Faresse N, Canella D, Praz V, Michaud J, Romascano D, Hernandez N. Genomic study of RNA polymerase II and III SNAPc-bound promoters reveals a gene transcribed by both enzymes and a broad use of common activators. PLoS Genet 2012; 8: e1003028.
47. Listerman I, Bledau AS, Grishina I, Neugebauer KM. Extragenic accumulation of RNA polymerase II enhances transcription by RNA polymerase III. PLoS Genet 2007; 3: e212.
48. Cramer P, Armache KJ, Baumli S, Benkert S, Brueckner F, Buchen C et al. Structure of eukaryotic RNA polymerases. Annu Rev Biophys 2008; 37: 337-352.
49. Marshall L, White RJ. Non-coding RNA production by RNA polymerase III is implicated in cancer. Nat Rev Cancer 2008; 8: 911-914.
50. Felton-Edkins ZA, Kenneth NS, Brown TR, Daly NL, Gomez-Roman N, Grandori C et al. Direct regulation of RNA polymerase III transcription by RB, p53 and c-Myc. Cell Cycle 2003; 2: 181-184.
51. Gomez-Roman N, Grandori C, Eisenman RN, White RJ. Direct activation of RNA polymerase III transcription by c-Myc. Nature 2003; 421: 290-294.
52. Crighton D, Woiwode A, Zhang C, Mandavia N, Morton JP, Warnock LJ et al. p53 represses RNA polymerase III transcription by targeting TBP and inhibiting promoter occupancy by TFIIIB. EMBO J 2003; 22: 2810-2820.
53. Pospisilova S, Gonzalez D, Malcikova J, Trbusek M, Rossi D, Kater AP et al. ERIC recommendations on TP53 mutation analysis in chronic lymphocytic leukemia. Leukemia 2012; 26: 1458-1461.
54. Rinaldi A, Mian M, Kwee I, Rossi D, Deambrogi C, Mensah AA et al. Genome-wide DNA profiling better defines the prognosis of chronic lymphocytic leukaemia. Br J Haematol 2011; 154: 590-599.
55. Put N, Van Roosbroeck K, Konings P, Meeus P, Brusselmans C, Rack K et al. Chronic lymphocytic leukemia and prolymphocytic leukemia with MYC translocations: a subgroup with an aggressive disease course. Ann Hematol 2012; 91: 863-873.
56. Cairns CA, White RJ. p53 is a general repressor of RNA polymerase III transcription. EMBO J 1998; 17: 3112-3123.
57. Stein T, Crighton D, Warnock LJ, Milner J, White RJ. Several regions of p53 are involved in repression of RNA polymerase III transcription. Oncogene 2002; 21: 5540-5547.
58. Chang TC, Yu D, Lee YS, Wentzel EA, Arking DE, West KM et al. Widespread microRNA repression by Myc contributes to tumorigenesis. Nat Genet 2008; 40: 43-50.
59. Ofir M, Hacohen D, Ginsberg D. MiR-15 and miR-16 are direct transcriptional targets of E2F1 that limit E2F-induced proliferation by targeting cyclin E. Mol Cancer Res 2011; 9: 440-447.
60. Kaplan D, Smith D, Meyerson H, Pecora N, Lewandowska K. CD5 expression by B lymphocytes and its regulation upon Epstein-Barr virus transformation. Proc Natl Acad Sci USA 2001; 98: 13850-13853.